|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,390.00 KRW | +1.61% |
|
+1.39% | -46.54% |
| Mar. 30 | Abpro Bio Co., Ltd. announced that it has received KRW 3.9999998 billion in funding | CI |
| Mar. 15 | Abpro Bio Co., Ltd. announced that it expects to receive KRW 6 billion in funding | CI |
Business description: Abpro Bio Co., Ltd.

Number of employees: 44
Sales by Activity: Abpro Bio Co., Ltd.
| Fiscal Period: December | 2021 (KRW) | 2022 (KRW) | 2023 (KRW) | 2024 (KRW) | 2025 (KRW) |
|---|---|---|---|---|---|
Pharmaceutical Sector | - | - | - | 6.5B | - |
Semiconductor Sector | - | - | 12.44B | 5.94B | - |
Elimination of Internal Transactions | -1.99B | -692M | -496M | -4.97B | - |
Machine Tool Sector | 34.9B | 22.8B | 13.43B | 24.2B | - |
Geographical breakdown of sales: Abpro Bio Co., Ltd.
| Fiscal Period: December | 2021 (KRW) | 2022 (KRW) | 2023 (KRW) | 2024 (KRW) | 2025 (KRW) |
|---|---|---|---|---|---|
China | 24.43B | 6.38B | 5.49B | 4.48B | - |
Other | 1.39B | 845M | 755M | 43.31M | - |
South Korea | 7.09B | 14.89B | 19.13B | 27.14B | - |
Executive Committee: Abpro Bio Co., Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
Jae-Yong Lee
CEO | Chief Executive Officer | 64 | 2024-04-29 |
Jong-Shik Hwang
SAM | Sales & Marketing | 56 | 2014-10-31 |
Composition of the Board of Directors: Abpro Bio Co., Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
Hyeong-Seok Kwon
BRD | Director/Board Member | 58 | 2020-04-08 |
Jin-Man Kwon
BRD | Director/Board Member | 56 | 2024-04-29 |
Jae-Yong Lee
BRD | Director/Board Member | 64 | 2019-08-22 |
Holdings: Abpro Bio Co., Ltd.
| Name | Equities | % | Valuation |
|---|---|---|---|
Abpro Holdings, Inc.
20.26% | 550,244 | 20.26% | 71 422 $ |
| 182 | 0% | 18 $ |
Company details: Abpro Bio Co., Ltd.

Machine Tools
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.61% | +1.39% | -53.82% | -77.62% | 26.69M | ||
| -0.64% | +7.95% | +112.06% | +48.23% | 2.96B | ||
| +0.76% | +3.58% | +0.30% | +9.00% | 2.58B | ||
| +2.16% | +8.98% | +65.97% | +42.20% | 2.61B | ||
| +1.57% | +16.48% | +184.30% | +337.29% | 2.39B | ||
| +4.40% | +9.23% | +14.07% | +29.52% | 2.37B | ||
| +1.39% | +5.89% | -15.36% | - | 2B | ||
| +11.67% | +19.60% | +137.38% | +434.32% | 2.04B | ||
| +0.53% | +5.15% | -5.74% | -19.32% | 1.82B | ||
| +2.01% | +17.25% | +382.54% | +425.79% | 1.83B | ||
| Average | +2.55% | +9.74% | +82.17% | +136.60% | 2.06B | |
| Weighted average by Cap. | +2.48% | +10.38% | +92.88% | +149.32% |
- Stock Market
- Equities
- A195990 Stock
- Company Abpro Bio Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions

















